Page last updated: 2024-10-27

fluoxetine and Lymphoma, T-Cell

fluoxetine has been researched along with Lymphoma, T-Cell in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frick, LR1
Palumbo, ML1
Zappia, MP1
Brocco, MA1
Cremaschi, GA1
Genaro, AM1

Other Studies

1 other study available for fluoxetine and Lymphoma, T-Cell

ArticleYear
Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms.
    Biochemical pharmacology, 2008, May-01, Volume: 75, Issue:9

    Topics: Animals; CD4-CD8 Ratio; Cell Line, Tumor; Cell Proliferation; Cytokines; Female; Fluoxetine; Immunit

2008